Trial Profile
A Randomized, Double Blind, Placebo-controlled, Multiple Dose Study to Assess the Efficacy, Safety and Pharmacokinetics of Oral Nalbuphine, an Oral Soft Capsule, for Post-hemorrhoidectomy Pain Management
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 23 Nov 2023
Price :
$35
*
At a glance
- Drugs Nalbuphine (Primary) ; Diclofenac
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors PhytoHealth
- 23 Nov 2023 Primary endpoint (the area under the curve of VAS pain intensity scores) has been met as per results published in the Clinical Journal of Pain.
- 23 Nov 2023 Results evaluating the safety and efficacy of PHN131 in patients undergoing hemorrhoidectomy, published in the Clinical Journal of Pain
- 26 Aug 2019 Status changed from active, no longer recruiting to completed.